Skip to main content
. 2013 Nov 13;73(1):151–161. doi: 10.1007/s00280-013-2333-4

Fig. 1.

Fig. 1

Change in biomarker [vascular endothelial growth factor (VEGF)-A, VEGF-C, interleukin-8 (IL-8) and soluble vascular endothelial growth factor receptor-3 (sVEGFR-3)] levels during treatment in the a sunitinib arm and b interferon-alpha arm. *P < 0.05; **P < 0.01; ***P < 0.0001 compared with baseline